These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 31699321)

  • 1. Disease-modifying therapy for proteinopathies: Can the exception become the rule?
    Bitan G
    Prog Mol Biol Transl Sci; 2019; 168():277-287. PubMed ID: 31699321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteinopathies, a core concept for understanding and ultimately treating degenerative disorders?
    Bayer TA
    Eur Neuropsychopharmacol; 2015 May; 25(5):713-24. PubMed ID: 23642796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathways of cellular proteostasis in aging and disease.
    Klaips CL; Jayaraj GG; Hartl FU
    J Cell Biol; 2018 Jan; 217(1):51-63. PubMed ID: 29127110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strain diversity in neurodegenerative disease: an argument for a personalized medicine approach to diagnosis and treatment.
    Woerman AL
    Acta Neuropathol; 2021 Jul; 142(1):1-3. PubMed ID: 33891174
    [No Abstract]   [Full Text] [Related]  

  • 5. Unravelling proteinopathies: an interview with David Rubinsztein.
    Rubinsztein D
    Dis Model Mech; 2015 Jul; 8(7):643-6. PubMed ID: 26092526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential roles of natural products in the targeting of proteinopathic neurodegenerative diseases.
    Dash R; Jahan I; Ali MC; Mitra S; Munni YA; Timalsina B; Hannan MA; Moon IS
    Neurochem Int; 2021 May; 145():105011. PubMed ID: 33711400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immunotherapy targeting misfolded proteins in neurodegenerative disease].
    Kanemaru K
    Brain Nerve; 2013 Apr; 65(4):469-74. PubMed ID: 23568995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteostasis and Proteotoxicity in the Network Medicine Era.
    Lualdi M; Alberio T; Fasano M
    Int J Mol Sci; 2020 Sep; 21(17):. PubMed ID: 32899160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurodegeneration in familial amyloidotic polyneuropathy.
    Gasperini RJ; Small DH
    Clin Exp Pharmacol Physiol; 2012 Aug; 39(8):680-3. PubMed ID: 21916933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Yeast, fish, fly--models to study the pathogenesis of proteinopathies and screen for interventions.
    Hausmann L; Schulz JB
    J Neurochem; 2013 Nov; 127(4):434. PubMed ID: 24188524
    [No Abstract]   [Full Text] [Related]  

  • 11. Current Concepts of Mixed Pathologies in Neurodegenerative Diseases.
    Forrest SL; Kovacs GG
    Can J Neurol Sci; 2023 May; 50(3):329-345. PubMed ID: 35356856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging potential of cannabidiol in reversing proteinopathies.
    Dash R; Ali MC; Jahan I; Munni YA; Mitra S; Hannan MA; Timalsina B; Oktaviani DF; Choi HJ; Moon IS
    Ageing Res Rev; 2021 Jan; 65():101209. PubMed ID: 33181336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro studies in VCP-associated multisystem proteinopathy suggest altered mitochondrial bioenergetics.
    Nalbandian A; Llewellyn KJ; Gomez A; Walker N; Su H; Dunnigan A; Chwa M; Vesa J; Kenney MC; Kimonis VE
    Mitochondrion; 2015 May; 22():1-8. PubMed ID: 25724235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. When good proteins go bad.
    Haelle T
    Sci Am; 2014 Oct; 311(4):19-20. PubMed ID: 25314857
    [No Abstract]   [Full Text] [Related]  

  • 15. Walking the tightrope: proteostasis and neurodegenerative disease.
    Yerbury JJ; Ooi L; Dillin A; Saunders DN; Hatters DM; Beart PM; Cashman NR; Wilson MR; Ecroyd H
    J Neurochem; 2016 May; 137(4):489-505. PubMed ID: 26872075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nucleic acid aptamers for neurodegenerative diseases.
    Bouvier-Müller A; Ducongé F
    Biochimie; 2018 Feb; 145():73-83. PubMed ID: 29104136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurodegenerative diseases linked to misfolded proteins and their therapeutic approaches: A review.
    Khanam H; Ali A; Asif M; Shamsuzzaman
    Eur J Med Chem; 2016 Nov; 124():1121-1141. PubMed ID: 27597727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective neuronal vulnerability in neurodegenerative diseases: from stressor thresholds to degeneration.
    Saxena S; Caroni P
    Neuron; 2011 Jul; 71(1):35-48. PubMed ID: 21745636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic approaches in proteinopathies.
    Afjadi MN; Dabirmanesh B; Uversky VN
    Prog Mol Biol Transl Sci; 2024; 206():341-388. PubMed ID: 38811085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathogenic mechanisms of prion protein, amyloid-β and α-synuclein misfolding: the prion concept and neurotoxicity of protein oligomers.
    Ugalde CL; Finkelstein DI; Lawson VA; Hill AF
    J Neurochem; 2016 Oct; 139(2):162-180. PubMed ID: 27529376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.